>> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. 상품명 정보
  2. GC16278 A-1210477 A-1210477은 0.45nM의 Ki를 갖는 MCL-1의 강력하고 선택적인 억제제입니다. A-1210477은 MCL-1에 특이적으로 결합하고 MCL-1 의존적 방식으로 암세포의 세포자멸사를 촉진한다. A-1210477  Chemical Structure
  3. GC17513 A-1331852 A-1331852는 Ki가 10pM 미만인 경구용 BCL-XL 선택적 억제제입니다. A-1331852  Chemical Structure
  4. GC60544 A-192621 A-192621은 IC50이 4.5nM이고 Ki가 8.8nM인 강력한 비펩타이드성 경구 활성 및 선택적 엔도텔린 B(ETB) 수용체 길항제입니다. A-192621  Chemical Structure
  5. GC32981 A-385358 A-385358은 Bcl-XL 및 Bcl-2에 대해 각각 0.80 및 67nM의 Kis를 갖는 Bcl-XL의 선택적 억제제입니다. A-385358  Chemical Structure
  6. GC91113 A011

    ATM 키나아제의 억제제

    A011  Chemical Structure
  7. GC11200 A23187

    Calcimycin

    A23187 (A-23187)은 항생제이자 칼슘과 마그네슘과 같은 독특한 이중양이온 이온포어입니다.

    A23187  Chemical Structure
  8. GC42659 A23187 (calcium magnesium salt)

    Calcimycin

    A23187 is a divalent cation ionophore.

    A23187 (calcium magnesium salt)  Chemical Structure
  9. GC35216 AAPK-25 AAPK-25는 항종양 활성이 있는 강력하고 선택적인 Aurora/PLK 이중 억제제로, 생체지표 히스톤 H3Ser10 인산화에 따라 세포자멸사 급증이 뒤따르는 전중기 단계에서 유사분열 지연 및 세포 정지를 유발할 수 있습니다. AAPK-25는 Kd 값이 23-289nM인 Aurora-A, -B 및 -C와 Kd 값이 55-456nM인 PLK-1, -2 및 -3을 대상으로 합니다. AAPK-25  Chemical Structure
  10. GC13805 Abacavir Abacavir  Chemical Structure
  11. GC64674 ABBV-167 ABBV-167은 BCL-2 억제제 베네토클락스의 인산염 전구약물이다. ABBV-167  Chemical Structure
  12. GC73269 ABBV-467 ABBV-467는 선택적 MCL-1억제제이다 (Ki:<0.01 nM). ABBV-467  Chemical Structure
  13. GC42677 ABO (hydrochloride) ABO is a modulator of annexin A7. ABO (hydrochloride)  Chemical Structure
  14. GC60548 ABT-100 ABT-100은 강력하고 선택성이 높으며 경구 활성인 파르네실트랜스퍼라제 억제제입니다. ABT-100은 세포 증식을 억제합니다. 2, PC-3 및 DU-145 세포)는 세포자멸사를 증가시키고 혈관신생을 감소시킨다. ABT-100은 광범위한 항종양 활성을 가지고 있습니다. ABT-100  Chemical Structure
  15. GC14069 ABT-199

    GDC 0199, Venetoclax

    Venetoclax(ABT-199,GDC-0199)은 세포무한실험에서 억제상수 Ki가 0.01 nM인 Bcl-2의 선택성 억제제이다. ABT-199  Chemical Structure
  16. GC12405 ABT-263 (Navitoclax)

    Navitoclax,ABT-263,ABT263,ABT 263

    ABT-263 (Navitoclax)은 Bcl-xL, Bcl-2 및 Bcl-w를 억제하는 억제제로 각각의 Ki ≤0.5 nM, ≤1 nM 및 ≤1 nM 가 있다. ABT-263 (Navitoclax)  Chemical Structure
  17. GC49745 ABT-263-d8

    Navitoclax-d8

    ABT-263-d8은 Navitoclax라고 표시된 중수소입니다. Navitoclax(ABT-263)는 Bcl-xL, Bcl-2 및 Bcl-w와 같은 여러 항-세포자멸사 Bcl-2 계열 단백질에 결합하는 강력하고 경구 활성인 Bcl-2 계열 단백질 억제제입니다. 1nM 이상. ABT-263-d8  Chemical Structure
  18. GC70733 ABT-510 acetate ABT-510 acetate 는 상피성 난소암 원위동유전자 모델에서 세포의 사멸을 유도하고 난소종양의 성장을 억제하는 항혈관생성 TSP펩타이드(혈소판반응단백질-1 유사물)의 일종이다. ABT-510 acetate  Chemical Structure
  19. GC17234 ABT-737

    ABT 737, ABT737

    An inhibitor of anti-apoptotic Bcl-2 proteins ABT-737  Chemical Structure
  20. GC90489 AC 187 (trifluoroacetate salt)

    칼시토닌 및 아밀린 수용체의 상대작용제

    AC 187 (trifluoroacetate salt)  Chemical Structure
  21. GC40122 Ac-AAVALLPAVLLALLAP-DEVD-CHO (trifluoroacetate salt)

    Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Glu-Val-Asp-CHO, Ac-AAVALLPAVLLALLAP-DEVD-aldehyde, Ac-AAVALLPAVLLALLAPDEVD-CHO, Caspase-3 Inhibitor I, DEVD-CHO-CPP 32

    Ac-AAVALLPAVLLALLAP-DEVD-CHO is a composite of Ac-DEVD-CHO, a peptide inhibitor of caspase-3 and -7, and a cell-permeable hydrophobic sequence derived from K-FGF. Ac-AAVALLPAVLLALLAP-DEVD-CHO (trifluoroacetate salt)  Chemical Structure
  22. GC40118 Ac-AAVALLPAVLLALLAP-IETD-CHO (trifluoroacetate salt)

    Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-CHO, Caspase-8 Inhibitor I

    Ac-AAVALLPAVLLALLAP-IETD-CHO is a composite of Ac-IETD-CHO, a peptide inhibitor of caspase-8, and a cell-permeable hydrophobic sequence derived from K-FGF. Ac-AAVALLPAVLLALLAP-IETD-CHO (trifluoroacetate salt)  Chemical Structure
  23. GC40123 Ac-AAVALLPAVLLALLAP-VAD-CHO (trifluoroacetate salt)

    Caspase Inhibitor II, Ac-AAVALLPAVLLALLAP-VAD-aldehyde, Ac-AAVALLPAVLLALLAPVAD-CHO

    Ac-AAVALLPAVLLALLAP-VAD-CHO is a composite of Ac-VAD-CHO, a non-selective caspase inhibitor, and a cell-permeable hydrophobic sequence derived from K-FGF. Ac-AAVALLPAVLLALLAP-VAD-CHO (trifluoroacetate salt)  Chemical Structure
  24. GA20494 Ac-Asp-Glu-Val-Asp-pNA

    Ac-Asp-Glu-Val-Asp-pNA

    The cleavage of the chromogenic caspase-3 substrate Ac-DEVD-pNA can be monitored at 405 nm. Ac-Asp-Glu-Val-Asp-pNA  Chemical Structure
  25. GC17602 Ac-DEVD-AFC

    N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-Trifluoromethylcoumarin,Caspase-3 Substrate (Fluorogenic)

    Ac-DEVD-AFC는 형광 기질입니다(Λex=400 nm, Λem=530 nm). Ac-DEVD-AFC  Chemical Structure
  26. GC32695 Ac-DEVD-CHO Ac-DEVD-CHO은 Caspase-3 억제제로서 IC50 값이 0.016μM이다. Ac-DEVD-CHO  Chemical Structure
  27. GC48470 Ac-DEVD-CHO (trifluoroacetate salt)

    N-Ac-Asp-Glu-Val-Asp-CHO

    A dual caspase3/caspase7 inhibitor Ac-DEVD-CHO (trifluoroacetate salt)  Chemical Structure
  28. GC10951 Ac-DEVD-CMK

    Ac-Asp-Glu-Val-Asp-CMK,Caspase-3 Inhibitor III

    cell-permeable, and irreversible inhibitor of caspase Ac-DEVD-CMK  Chemical Structure
  29. GC48430 Ac-DEVD-CMK (trifluoroacetate salt)

    AcAspGluValAspCMK, Caspase3 Inhibitor III

    Ac-DEVD-CMK (trifluoroacetate salt)  Chemical Structure
  30. GC68600 Ac-DEVD-CMK TFA

    Caspase-3 Inhibitor III TFA

    Ac-DEVD-CMK (Caspase-3 Inhibitor III) TFA는 선택적이고 불가역적인 카스패이스-3 억제제입니다. Ac-DEVD-CMK TFA는 고수준의 포도당 또는 3,20-dibenzoate (IDB; 5) 유도에 의한 세포사멸을 유의하게 억제합니다. Ac-DEVD-CMK TFA는 다양한 실험 방법에서 세포사멸을 억제하기 위해 사용될 수 있습니다.

    Ac-DEVD-CMK TFA  Chemical Structure
  31. GC42687 Ac-DMQD-AMC (trifluoroacetate salt)

    Ac-Asp-Met-Gln-Asp-AMC, Ac-Asp-Met-Gln-Asp-7-amino-4-methylcoumarin

    Ac-DMQD-AMC is a fluorogenic substrate for caspase-3. Ac-DMQD-AMC (trifluoroacetate salt)  Chemical Structure
  32. GC42688 Ac-DMQD-CHO (trifluoroacetate salt)

    Ac-Asp-Met-Gln-Asp-CHO, Caspase-3 Inhibitor

    Ac-DMQD-CHO is a peptide inhibitor of caspase-3 (IC50 = 39 nM). Ac-DMQD-CHO (trifluoroacetate salt)  Chemical Structure
  33. GC42689 Ac-DNLD-AMC

    Ac-Asp-Asn-Leu-Asp-MCA, N-Acetyl-Asp-Asn-Leu-Asp-7-amido-Methylcoumarin, Caspase-3 Substrate

    Ac-WLA-AMC는 caspase-3의 형광 기질입니다. Ac-DNLD-AMC  Chemical Structure
  34. GC40154 Ac-ESMD-CHO (trifluoroacetate salt)

    Ac-Glu-Ser-Met-Asp-CHO

    Ac-ESMD-CHO is an inhibitor of caspase-3 maturation. Ac-ESMD-CHO (trifluoroacetate salt)  Chemical Structure
  35. GC65107 Ac-FEID-CMK TFA Ac-FEID-CMK TFA는 강력한 제브라피쉬 특이적 GSDMEb 유래 펩타이드 억제제입니다. Ac-FEID-CMK TFA  Chemical Structure
  36. GC60558 Ac-FLTD-CMK Gasdermin D(GSDMD) 유래 억제제인 Ac-FLTD-CMK는 특정 염증성 카스파제 억제제입니다. Ac-FLTD-CMK  Chemical Structure
  37. GC49704 Ac-FLTD-CMK (trifluoroacetate salt)

    Ac-Phe-Leu-Thr-Asp-CMK

    An inhibitor of caspase-1, -4, -5, and -11 Ac-FLTD-CMK (trifluoroacetate salt)  Chemical Structure
  38. GC40152 Ac-IEPD-pNA (trifluoroacetate salt)

    Ac-Ile-Glu-Pro-Asp-p-nitroanilide, Caspase-8 Chromogenic Substrate, Granzyme B Substrate VIII

    Ac-IEPD-pNA is a colorimetric substrate for granzyme B and caspase-8. Ac-IEPD-pNA (trifluoroacetate salt)  Chemical Structure
  39. GC40164 Ac-IETD-CHO (trifluoroacetate salt)

    Caspase-8 Inhibitor

    Ac-IETD-CHO is an inhibitor of caspase-8 (IC50 = 5 nM).

    Ac-IETD-CHO (trifluoroacetate salt)  Chemical Structure
  40. GC42708 Ac-LEHD-AFC (trifluoroacetate salt)

    N-Acetyl-Leu-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase-9 substrate (Fluorogenic)

    Ac-LEHD-AFC is a fluorogenic substrate that can be cleaved by caspase-4, -5, and -9. Ac-LEHD-AFC (trifluoroacetate salt)  Chemical Structure
  41. GC18226 Ac-LEHD-AMC (trifluoroacetate salt)

    Ac-Leu-Glu-His-Asp-AMC, Caspase-9 Substrate

    Ac-LEHD-AMC(트리플루오로아세테이트 염)는 카스파제-9에 대한 형광 기질입니다(여기: 341 nm, 방출: 441 nm). Ac-LEHD-AMC (trifluoroacetate salt)  Chemical Structure
  42. GC46791 Ac-LEHD-pNA (trifluoroacetate salt)

    Ac-Leu-Glu-His-Asp-pNA, Caspase-9 Chromogenic Substrate I

    A neuropeptide with diverse biological activities Ac-LEHD-pNA (trifluoroacetate salt)  Chemical Structure
  43. GC40556 Ac-LETD-AFC

    NAcetylLeuGluThrAsp7amino4Trifluoromethylcoumarin, Caspase8 Substrate (Fluorogenic)

    Ac-LETD-AFC는 카스파제-8 형광 기질입니다. Ac-LETD-AFC  Chemical Structure
  44. GC42709 Ac-LEVD-CHO (trifluoroacetate salt)

    Ac-Leu-Glu-Val-Asp-CHO, Caspase-4 Inhibitor I

    Ac-LEVD-CHO is a caspase-4 inhibitor.

    Ac-LEVD-CHO (trifluoroacetate salt)  Chemical Structure
  45. GC13400 Ac-VDVAD-AFC

    N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin Caspase-2 Substrate (Fluorogenic)

    Ac-VDVAD-AFC는 카스파제 특이적 형광 기질입니다. Ac-VDVAD-AFC는 caspase-3-like 활성 및 caspase-2 활성을 측정할 수 있으며 종양 및 암 연구에 사용할 수 있습니다. Ac-VDVAD-AFC  Chemical Structure
  46. GC52372 Ac-VDVAD-AFC (trifluoroacetate salt)

    N-Acetyl-Val-Asp-Val-Ala-Asp-AFC, N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase-2 Substrate (Fluorogenic)

    A fluorogenic substrate for caspase-2 Ac-VDVAD-AFC (trifluoroacetate salt)  Chemical Structure
  47. GC42716 Ac-VDVAD-pNA (trifluoroacetate salt)

    Ac-Val-Asp-Val-Ala-Asp-pNA, Caspase-2 Chromogenic Substrate, acetyl-Val-Asp-Val-Ala-Asp-p-nitroanilide, acetyl-VDVAD-p-nitroanilide

    Ac-VDVAD-pNA is a colorimetric substrate for caspase-2. Ac-VDVAD-pNA (trifluoroacetate salt)  Chemical Structure
  48. GC48974 Ac-VEID-AMC (ammonium acetate salt)

    NAcetylValGluIleAsp7amido4Methylcoumarin, Caspase6 Substrate (Fluorogenic)

    A caspase-6 fluorogenic substrate Ac-VEID-AMC (ammonium acetate salt)  Chemical Structure
  49. GC42718 Ac-VEID-CHO (trifluoroacetate salt)

    Ac-Val-Glu-Ile-Asp-CHO

    Ac-VEID-CHO is an inhibitor of caspase-6 (IC50 = 16.2 nM). Ac-VEID-CHO (trifluoroacetate salt)  Chemical Structure
  50. GC70289 AC-VEID-CHO TFA AC-VEID-CHO TFA은 펩타이드 유래 caspase 저해제이며 IC50 값이 각각 16.2 nM, 13.6 nM, 162.1 nM인 Caspase-6, Caspase-3, Caspase-7에 대한 억제 효능을 가지고 있다. AC-VEID-CHO TFA  Chemical Structure
  51. GC40162 Ac-VEID-pNA (trifluoroacetate salt)

    Ac-Val-Glu-Ile-Asp-pNA, Ac-Val-Glu-Ile-Asp-p-nitroanilide, Caspase-6 Chromogenic Substrate

    Ac-VEID-pNA is a substrate for caspase-6. Ac-VEID-pNA (trifluoroacetate salt)  Chemical Structure
  52. GC74380 Ac-VRPR-AMC TFA Ac-VRPR-AMC TFA는 fluorogenic metacaspase 기질입니다. Ac-VRPR-AMC TFA  Chemical Structure
  53. GC40124 Ac-WEAD-AMC (trifluoroacetate salt)

    Ac-Trp-Glu-Ala-Asp-AMC

    Ac-WEAD-AMC is a fluorogenic substrate for caspase-1 and caspase-4. Ac-WEAD-AMC (trifluoroacetate salt)  Chemical Structure
  54. GC42719 Ac-WEAD-pNA (trifluoroacetate salt)

    Ac-Trp-Glu-Ala-Asp-pNA, Ac-Trp-Glu-Ala-Asp-p-nitroanilide, Caspase-1 and Caspase-4 Chromogenic Substrate

    Ac-WEAD-pNA is a colorimetric substrate for caspase-1 and caspase-4. Ac-WEAD-pNA (trifluoroacetate salt)  Chemical Structure
  55. GC46796 Ac-WEHD-AFC (trifluoroacetate salt)

    N-Acetyl-Trp-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase1 Substrate (Fluorogenic), Caspase5 Substrate (Fluorogenic)

    A neuropeptide with diverse biological activities Ac-WEHD-AFC (trifluoroacetate salt)  Chemical Structure
  56. GC68621 Ac-WEHD-AFC TFA

    Ac-WEHD-AFC TFA는 형광 caspase-1 기질입니다. Ac-WEHD-AFC TFA는 종양 및 염증 연구에 사용되며 caspase-1 형광 활성을 감지할 수 있습니다.

    Ac-WEHD-AFC TFA  Chemical Structure
  57. GC18021 Ac-YVAD-CHO

    Caspase-1 Inhibitor I, L 709049, N-Ac-Tyr-Val-Ala-Asp-CHO

    Ac-YVAD-CHO(L-709049)는 3.0 및 0.76nM의 마우스 및 인간 Ki 값을 갖는 강력하고 가역적인 특이적 테트라펩타이드 인터루킨-1β 전환 효소(ICE) 억제제입니다. Ac-YVAD-CHO  Chemical Structure
  58. GC42721 Ac-YVAD-CMK

    N-Ac-Tyr-Val-Ala-Asp-CMK

    Ac-YVAD-CMK 되돌 릴 수 없는 선택적 억제 제야의 caspase-1 (Ki=0.8nM), proinflammatory을 방지 할 수 있는 사이토 카인 IL-1 β 활성화다.Ac-YVAD-CMK는 염증 반응을 줄이고 오래 지속되는 신경 보호 효과를 유도할 수 있다. Ac-YVAD-CMK  Chemical Structure
  59. GC74500 Acasunlimab

    GEN1046

    Acasunlimab (GEN1046)은 PD-L1과 4-1BB를 타겟으로 하는 bispecific antibody (bsAb)이다. Acasunlimab  Chemical Structure
  60. GC35227 ACBI1 ACBI1은 각각 6, 11 및 32nM의 DC50을 갖는 강력하고 협력적인 SMARCA2, SMARCA4 및 PBRM1 분해기입니다. ACBI1은 PROTAC 분해제입니다. ACBI1은 항증식 활성을 나타냅니다. ACBI1은 세포 사멸을 유도합니다. ACBI1  Chemical Structure
  61. GN10341 Acetate gossypol Acetate gossypol  Chemical Structure
  62. GC11786 Acetylcysteine

    N-acetylcysteine; N-acetyl-L-cysteine; NAC; Acetadote

    Acetylcysteine은 CYSTEINE의 N-acetyl 유도체이다. Acetylcysteine  Chemical Structure
  63. GC17094 Acitretin

    all-trans Acitretin, Ro 10-1670, Ro 10-1670/000

    아시트레틴(Ro 10-1670)은 건선 치료에 사용된 2세대 전신 레티노이드입니다. Acitretin  Chemical Structure
  64. GC35242 Actein 악테인은 Cimicifuga foetida의 뿌리줄기에서 분리된 트리테르펜 배당체입니다. 액테인은 인간 방광암에서 ROS/JNK 활성화를 촉진하고 AKT 경로를 둔화시켜 세포 증식을 억제하고 자가포식 및 세포자멸사를 유도합니다. 액테인은 생체 내 독성이 거의 없습니다. Actein  Chemical Structure
  65. GC16866 Actinomycin D

    Cosmegen, Dactinomycin, Meractinomycin, NCI C04682, NSC 3053, Oncostatin K

    Actinomycin D (dactinomycin)은 스트렙토마이세스 종에서 분리된 천연 크로모펩타이드로 하나의 이소사이클릭로포어 및 두 개의 순환 펜타펩타이드 락톤 고리가 있다. Actinomycin D  Chemical Structure
  66. GC70584 Actinomycin X2 Actinomycin X2 (방선균소 V), 많은 스트렙토마이신에서 생성됩니다. Actinomycin X2  Chemical Structure
  67. GC16350 Actinonin

    (-)-Actinonin,Ro 06-1467

    Actinonin ((-)-Actinonin)은 Actinomyces에 의해 생성되는 자연 발생 항균제입니다. Actinonin  Chemical Structure
  68. GC16362 AD57 (hydrochloride) polypharmacological cancer therapeutic that inhibits RET. AD57 (hydrochloride)  Chemical Structure
  69. GC34214 Adalimumab (Anti-Human TNF-alpha, Human Antibody) Adalimumab (Anti-Human TNF-alpha, Human Antibody)은 류머티스관절염을 치료하는 대표적인 약물 중의 하나다. Adalimumab (Anti-Human TNF-alpha, Human Antibody)  Chemical Structure
  70. GC10610 Adapalene

    CD 271

    3세대 합성 레티노이드인 아다팔렌(CD271)은 여드름 연구에 널리 사용됩니다. Adapalene  Chemical Structure
  71. GC46798 Adapalene-d3 An internal standard for the quantification of adapalene Adapalene-d3  Chemical Structure
  72. GC13959 Adarotene

    ST1926

    An atypical retinoid Adarotene  Chemical Structure
  73. GC74501 Adebrelimab

    SHR-1316

    Adebrelimab (SHR-1316) 는 인적 자원화 IgG4 단일 클론 PD-L1 (PD-1/PD-L1) 항체입니다. Adebrelimab  Chemical Structure
  74. GC65880 ADH-6 TFA ADH-6 TFA는 트리피리딜아미드 화합물입니다. 821d96072c2d58d8970e76f526b0f6b8ADH-6은 돌연변이 p53 DBD의 응집-핵화 서브도메인의 자기 조립을 폐지합니다. 821d96072c2d58d8970e76f526b0f6b8ADH-6 TFA는 인간 암 세포에서 돌연변이 p53 응집체를 표적으로 삼고 분리하여 p53'의 전사 활성을 복원하여 세포 주기 정지 및 세포 사멸을 유도합니다. 821d96072c2d58d8970e76f526b0f6b8ADH-6 TFA는 암 질환 연구에 잠재력이 있습니다.821d96072c2d58d8970e76f526b0f6b8 ADH-6 TFA  Chemical Structure
  75. GC42735 Adipostatin A

    NSC 776, 5-pentadecyl Resorcinol

    아디포스타틴 A(아디포스타틴 A)는 IC50이 4.1 μ인 글리세롤-3-인산 탈수소효소(GPDH) 억제제입니다. Adipostatin A  Chemical Structure
  76. GC11892 AEE788 (NVP-AEE788)

    NVP-AEE788

    AEE788(NVP-AEE788)은 IC50 값이 각각 2 및 6 nM인 EGFR 및 ErbB2의 억제제입니다. AEE788 (NVP-AEE788)  Chemical Structure
  77. GC42743 AEM1 AEM1은 Nrf2 억제제입니다. AEM1은 A549 세포에서 Nrf2 의존성 유전자의 발현을 감소시키고 시험관 내 및 생체 내에서 A549 세포의 성장을 억제합니다. AEM1  Chemical Structure
  78. GC72386 Afelimomab Afelimomab (MAK 195F)는 항종양 괴사인자 F (ab') 2 단일 클론 항체 조각입니다. Afelimomab  Chemical Structure
  79. GC13168 AG 825

    Tyrphostin AG825

    AG 825(Tyrphostin AG 825)는 0.35μM의 IC50으로 티로신 인산화를 억제하는 선택적 ATP 경쟁 ErbB2 억제제입니다. AG 825  Chemical Structure
  80. GC13697 AG-1024

    AGS 200, Tyrphostin AG1024

    AG-1024는 IC50 값이 7µM인 가역적, 경쟁적이고 선택적인 인슐린 유사 성장 인자-1 수용체(IGF-1R) 억제제이다. AG-1024는 인슐린 수용체(IR)의 인산화를 IC50 값이 57µM인 수준으로 억제할 수 있다. AG-1024  Chemical Structure
  81. GC17881 AGK 2 AGK 2는 선택적 SIRT2 억제제로 IC50가 3.5 µM이다. AGK2는 SIRT1과 SIRT3를 IC50 30과 91 µM로 억제한다. AGK 2  Chemical Structure
  82. GC39584 AGN194204

    IRX4204; NRX194204; VTP 194204

    AGN194204 (IRX4204)는 RXRα, RXRβ 및 RXRγ에 대한 Kd 값이 각각 0.4 nM, 3.6 nM 및 3.8 nM이며, 이들에 대한 EC50은 각각 0.2 nM, 0.8 nM 및 0.08 nM인 경구 흡수 가능하고 선택적인 RXR 작용제입니다.

    AGN194204  Chemical Structure
  83. GC16120 AI-3 Nrf2/Keap1 and Keap1/Cul3 interaction inhibitor AI-3  Chemical Structure
  84. GC46821 Ajoene 마늘에서 추출한 화합물인 아조엔은 항혈전 및 항진균제입니다. Ajoene  Chemical Structure
  85. GC68632 AK-778-XXMU

    AK-778-XXMU는 DNA 결합 2(ID2) 억제제의 효과적인 억제제로, KD는 129 nM입니다. AK-778-XXMU는 신경교종 세포주의 이동 및 침습을 억제하며, 세포 자살(apoptosis)을 유도하고 더 중요한 것은 종양 성장을 감소시킬 수 있습니다.

    AK-778-XXMU  Chemical Structure
  86. GC39620 AKOS-22 AKOS-22  Chemical Structure
  87. GC11589 AKT inhibitor VIII A potent inhibitor of Akt1 and Akt2 AKT inhibitor VIII  Chemical Structure
  88. GC35275 AKT-IN-3 AKT-IN-3(화합물 E22)은 Akt1, Akt2 및 Akt3에 대해 각각 1.4nM, 1.2nM 및 1.7nM인 강력한 경구 활성 낮은 hERG 차단 Akt 억제제입니다. AKT-IN-3(화합물 E22)는 또한 PKA, PKC, ROCK1, RSK1, P70S6K 및 SGK와 같은 다른 AGC 계열 키나제에 대해 우수한 억제 활성을 나타냅니다. AKT-IN-3(화합물 E22)는 세포자멸사를 유도하고 암세포의 전이를 억제합니다. AKT-IN-3  Chemical Structure
  89. GC19897 Albendazole Sulfone

    ABZ-SO2, ABZ-SOO

    Albendazole sulfone은 Albendazole의 대사산물로 Echinococcus multilocularis Metacestodes에 대해 항기생충 효과를 나타낸다. Albendazole Sulfone  Chemical Structure
  90. GC49773 Albendazole sulfone-d3

    ABZ-SO2-d3, ABZ-SOO-d3

    An internal standard for the quantification of albendazole sulfone Albendazole sulfone-d3  Chemical Structure
  91. GC48848 Albendazole-d7

    ABZ-d7

    Albendazole-d7(SKF-62979-d7)은 Albendazole로 표시된 중수소입니다. Albendazole-d7  Chemical Structure
  92. GC41080 Albofungin

    Antibiotic P42-1, Antibiotic P42-C

    Albofungin is a xanthone isolated from A. Albofungin  Chemical Structure
  93. GC16597 Alda 1 Alda 1은 강력하고 선택적인 ALDH2 작용제로서 야생형 ALDH2를 활성화하고 ALDH2*2에 대해 야생형에 가까운 활성을 회복합니다. Alda 1  Chemical Structure
  94. GC73642 ALK-IN-26 ALK-IN-26은 IC50와 함께 ALK 억제 ALK 값의 7. 0 μ M-dopa 산화효소다. ALK-IN-26  Chemical Structure
  95. GC35288 Alkannin

    (-)-Alkannin, NSC 94524

    Alkanna tinctoria에서 발견되는 Alkannin은 식용 색소로 사용됩니다. Alkannin  Chemical Structure
  96. GC40094 all-trans Retinoic Acid-d5

    atRA-d5, RA-d5, Vitamin A Acid-d5

    all-trans Retinoic acid-d5 is intended for use as an internal standard for the quantification of all-trans retinoic acid by GC- or LC-MS. all-trans Retinoic Acid-d5  Chemical Structure
  97. GC49393 all-trans-13,14-Dihydroretinol A metabolite of all-trans retinoic acid all-trans-13,14-Dihydroretinol  Chemical Structure
  98. GC32127 Alofanib (RPT835)

    RPT835

    알로파닙(RPT835)(RPT835)은 섬유아세포 성장 인자 수용체 2(FGFR2)의 강력하고 선택적인 알로스테릭 억제제입니다. Alofanib (RPT835)  Chemical Structure
  99. GC14314 Aloperine 알로페린은 항암, 항염증 및 항바이러스 특성을 나타내는 Sophora 식물의 알칼로이드입니다. Aloperine  Chemical Structure
  100. GC35306 alpha-Mangostin 알파-망고스틴(α-Mangostin)은 항산화, 항알레르기, 항바이러스, 항균, 항염 및 항암 효과와 같은 광범위한 생물학적 활성을 갖는 식이 크산톤입니다. Ki가 2.85μM인 돌연변이 IDH1(IDH1-R132H)의 억제제입니다. alpha-Mangostin  Chemical Structure
  101. GC18437 Alternariol monomethyl ether

    AME, NSC 638262

    Anthocleista djalonensis(Loganiaceae)의 뿌리에서 분리된 Alternariol monomethyl ether는 식물 종의 중요한 분류학적 표지자입니다. Alternariol monomethyl ether  Chemical Structure

Items 201 to 300 of 2711 total

페이지 당
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

내림차순